Predicted Trait | |
Reported Trait | Melanoma |
Mapped Trait(s) | melanoma (EFO_0000756) |
Score Construction | |
PGS Name | PRS22_melanoma |
Development Method | |
Name | Genome-wide significant variants |
Parameters | r2>=0.93 |
Variants | |
Original Genome Build | hg19 |
Number of Variants | 22 |
Effect Weight Type | NR |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000328 |
Citation (link to publication) | Choi J et al. Int J Cancer (2020) |
Ancestry Distribution | |
Source of Variant Associations (GWAS) | European: 100% 291,407 individuals (100%) |
PGS Evaluation | European: 100% 1 Sample Sets |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
GWAS Catalog: GCST004142 Europe PMC: 28212542 |
291,407 individuals | European | 23andMe |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM013030 | PSS009664| European Ancestry| 1,226 individuals |
PGP000328 | Choi J et al. Int J Cancer (2020) |
Reported Trait: Melanoma | — | AUROC: 0.59 [0.55, 0.63] | — | — | — |
PPM013038 | PSS009664| European Ancestry| 1,226 individuals |
PGP000328 | Choi J et al. Int J Cancer (2020) |
Reported Trait: Melanoma | — | — | Hazard ratio (HR top 5% vs average): 2.31 [1.85, 2.88] | Age, birth cohort, genotyping array, top 10 PCs for ancestry and sex (for nonsex specific cancer only) | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS009664 | melanoma (ICD-9 = 172 or ICD-10 = C43) | — | 1,226 individuals | — | European | — | UKB | — |